 Michele Yang
Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscular Dystrophy, Duchenne | 5 | 2024 | 99 | 0.750 |
Why?
| | Body Height | 3 | 2016 | 201 | 0.600 |
Why?
| | Body Weight | 3 | 2016 | 973 | 0.470 |
Why?
| | Neuromuscular Diseases | 1 | 2016 | 124 | 0.430 |
Why?
| | Child Development | 1 | 2016 | 474 | 0.350 |
Why?
| | Spinal Muscular Atrophies of Childhood | 3 | 2014 | 17 | 0.320 |
Why?
| | Myopathies, Structural, Congenital | 2 | 2019 | 6 | 0.310 |
Why?
| | Body Mass Index | 3 | 2016 | 2369 | 0.300 |
Why?
| | Motor Neurons | 3 | 2016 | 236 | 0.300 |
Why?
| | Myelitis | 2 | 2017 | 107 | 0.240 |
Why?
| | Survival of Motor Neuron 1 Protein | 2 | 2014 | 12 | 0.220 |
Why?
| | Pregnadienediols | 1 | 2024 | 4 | 0.220 |
Why?
| | Respiration, Artificial | 2 | 2019 | 643 | 0.220 |
Why?
| | Dystrophin | 1 | 2023 | 35 | 0.200 |
Why?
| | Child, Preschool | 14 | 2024 | 11097 | 0.200 |
Why?
| | Action Potentials | 3 | 2014 | 502 | 0.190 |
Why?
| | Muscle, Skeletal | 3 | 2017 | 1701 | 0.180 |
Why?
| | Polyneuropathies | 2 | 2014 | 55 | 0.170 |
Why?
| | Leukodystrophy, Globoid Cell | 1 | 2020 | 8 | 0.170 |
Why?
| | Prednisone | 2 | 2024 | 245 | 0.170 |
Why?
| | Adaptation, Physiological | 2 | 2014 | 546 | 0.170 |
Why?
| | Neurology | 1 | 2021 | 114 | 0.160 |
Why?
| | Mutation, Missense | 2 | 2019 | 338 | 0.160 |
Why?
| | Patient Admission | 1 | 2021 | 191 | 0.160 |
Why?
| | Neural Conduction | 3 | 2017 | 86 | 0.160 |
Why?
| | Alcohol Oxidoreductases | 1 | 2019 | 62 | 0.150 |
Why?
| | Nervous System Diseases | 1 | 2021 | 265 | 0.150 |
Why?
| | Patient Safety | 1 | 2021 | 305 | 0.140 |
Why?
| | Neuroimaging | 1 | 2020 | 291 | 0.140 |
Why?
| | Premature Birth | 2 | 2019 | 331 | 0.140 |
Why?
| | Cranial Nerve Diseases | 1 | 2017 | 42 | 0.130 |
Why?
| | Movement Disorders | 1 | 2017 | 59 | 0.130 |
Why?
| | Muscular Diseases | 1 | 2017 | 115 | 0.130 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2020 | 389 | 0.130 |
Why?
| | Infant | 8 | 2020 | 9467 | 0.130 |
Why?
| | Muscle Weakness | 2 | 2014 | 87 | 0.130 |
Why?
| | Pregnenediones | 1 | 2016 | 21 | 0.130 |
Why?
| | Paralysis | 1 | 2016 | 70 | 0.120 |
Why?
| | Muscular Dystrophy, Emery-Dreifuss | 1 | 2015 | 3 | 0.120 |
Why?
| | Glucocorticoids | 2 | 2020 | 599 | 0.120 |
Why?
| | Respiration Disorders | 1 | 2016 | 77 | 0.120 |
Why?
| | Cytoplasmic Dyneins | 1 | 2015 | 8 | 0.120 |
Why?
| | Cohort Studies | 5 | 2020 | 5730 | 0.120 |
Why?
| | Surgical Procedures, Operative | 1 | 2017 | 256 | 0.120 |
Why?
| | Muscular Atrophy, Spinal | 1 | 2015 | 23 | 0.120 |
Why?
| | Child | 14 | 2024 | 22037 | 0.120 |
Why?
| | Enterovirus D, Human | 1 | 2016 | 85 | 0.110 |
Why?
| | Gastrostomy | 1 | 2016 | 113 | 0.110 |
Why?
| | Infant, Newborn | 4 | 2020 | 6059 | 0.110 |
Why?
| | Enteral Nutrition | 1 | 2016 | 200 | 0.110 |
Why?
| | Enterovirus Infections | 1 | 2016 | 175 | 0.110 |
Why?
| | Growth | 1 | 2013 | 61 | 0.100 |
Why?
| | Actins | 1 | 2015 | 416 | 0.100 |
Why?
| | Male | 17 | 2024 | 67718 | 0.100 |
Why?
| | Respiratory Mechanics | 1 | 2012 | 67 | 0.100 |
Why?
| | Muscular Dystrophies | 1 | 2012 | 36 | 0.100 |
Why?
| | Telemedicine | 1 | 2021 | 852 | 0.100 |
Why?
| | Aspartate Aminotransferases | 1 | 2012 | 91 | 0.100 |
Why?
| | Weight Gain | 1 | 2016 | 518 | 0.090 |
Why?
| | Follow-Up Studies | 3 | 2017 | 5139 | 0.090 |
Why?
| | Alanine Transaminase | 1 | 2012 | 158 | 0.090 |
Why?
| | Motor Skills | 1 | 2012 | 101 | 0.090 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1507 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 2 | 2020 | 3722 | 0.080 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2681 | 0.080 |
Why?
| | Humans | 21 | 2024 | 137514 | 0.080 |
Why?
| | Emergency Service, Hospital | 1 | 2021 | 2054 | 0.080 |
Why?
| | Muscle Strength | 1 | 2012 | 315 | 0.080 |
Why?
| | Critical Illness | 1 | 2014 | 809 | 0.070 |
Why?
| | Retrospective Studies | 5 | 2019 | 15628 | 0.070 |
Why?
| | Arthritis, Psoriatic | 1 | 2007 | 21 | 0.070 |
Why?
| | Female | 12 | 2021 | 73162 | 0.070 |
Why?
| | Adolescent | 8 | 2020 | 21555 | 0.070 |
Why?
| | Electromyography | 3 | 2017 | 400 | 0.070 |
Why?
| | Young Adult | 6 | 2020 | 13243 | 0.060 |
Why?
| | Disease Progression | 3 | 2020 | 2755 | 0.060 |
Why?
| | Phenotype | 3 | 2019 | 3205 | 0.050 |
Why?
| | Mutation | 1 | 2015 | 3964 | 0.050 |
Why?
| | Utrophin | 1 | 2023 | 7 | 0.050 |
Why?
| | Sarcolemma | 1 | 2023 | 41 | 0.050 |
Why?
| | Muscles | 1 | 2023 | 325 | 0.050 |
Why?
| | Age Factors | 2 | 2019 | 3301 | 0.040 |
Why?
| | Adult | 7 | 2021 | 37821 | 0.040 |
Why?
| | Tooth Abnormalities | 1 | 2019 | 13 | 0.040 |
Why?
| | Muscle Hypotonia | 1 | 2019 | 33 | 0.040 |
Why?
| | Ataxia | 1 | 2019 | 45 | 0.040 |
Why?
| | Biomarkers | 2 | 2024 | 4172 | 0.030 |
Why?
| | Intellectual Disability | 1 | 2019 | 165 | 0.030 |
Why?
| | Prospective Studies | 3 | 2014 | 7598 | 0.030 |
Why?
| | Atrophy | 1 | 2017 | 184 | 0.030 |
Why?
| | Echocardiography | 1 | 2020 | 659 | 0.030 |
Why?
| | Stroke Volume | 1 | 2020 | 619 | 0.030 |
Why?
| | Alleles | 1 | 2019 | 891 | 0.030 |
Why?
| | Longitudinal Studies | 2 | 2014 | 2857 | 0.030 |
Why?
| | Myopathies, Nemaline | 1 | 2015 | 2 | 0.030 |
Why?
| | Glioblastoma | 1 | 2019 | 344 | 0.030 |
Why?
| | Mortality | 1 | 2017 | 357 | 0.030 |
Why?
| | Brain | 2 | 2020 | 2831 | 0.030 |
Why?
| | Chromatin | 1 | 2019 | 524 | 0.030 |
Why?
| | Genetic Linkage | 1 | 2015 | 299 | 0.030 |
Why?
| | Middle Aged | 4 | 2021 | 33355 | 0.030 |
Why?
| | Sural Nerve | 1 | 2014 | 19 | 0.030 |
Why?
| | Peroneal Nerve | 1 | 2014 | 19 | 0.030 |
Why?
| | Exome | 1 | 2015 | 231 | 0.030 |
Why?
| | Pedigree | 1 | 2015 | 514 | 0.030 |
Why?
| | Fibroblasts | 1 | 2019 | 990 | 0.030 |
Why?
| | Neurologic Examination | 1 | 2014 | 113 | 0.030 |
Why?
| | Homozygote | 1 | 2014 | 203 | 0.030 |
Why?
| | Electrophysiology | 1 | 2014 | 221 | 0.030 |
Why?
| | Age of Onset | 1 | 2015 | 522 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2017 | 403 | 0.030 |
Why?
| | Leg | 1 | 2015 | 223 | 0.030 |
Why?
| | Exons | 1 | 2014 | 349 | 0.030 |
Why?
| | Protein Binding | 1 | 2019 | 2229 | 0.020 |
Why?
| | Clinical Enzyme Tests | 1 | 2012 | 11 | 0.020 |
Why?
| | Quality Improvement | 1 | 2021 | 1161 | 0.020 |
Why?
| | Gene Deletion | 1 | 2014 | 393 | 0.020 |
Why?
| | Proteomics | 1 | 2019 | 1113 | 0.020 |
Why?
| | Unnecessary Procedures | 1 | 2012 | 49 | 0.020 |
Why?
| | Incidental Findings | 1 | 2012 | 87 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 851 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 2066 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 3420 | 0.020 |
Why?
| | Early Diagnosis | 1 | 2012 | 244 | 0.020 |
Why?
| | Family | 1 | 2015 | 667 | 0.020 |
Why?
| | Apoptosis | 1 | 2019 | 2557 | 0.020 |
Why?
| | Brain Neoplasms | 1 | 2019 | 1241 | 0.020 |
Why?
| | Intensive Care Units | 1 | 2014 | 803 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3546 | 0.020 |
Why?
| | Sepsis | 1 | 2014 | 611 | 0.020 |
Why?
| | Colorado | 1 | 2017 | 4521 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 10356 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2015 | 7593 | 0.010 |
Why?
| | Aged | 2 | 2014 | 23798 | 0.010 |
Why?
| | Quality of Life | 1 | 2012 | 2870 | 0.010 |
Why?
| | Animals | 1 | 2023 | 37011 | 0.010 |
Why?
| | United States | 1 | 2016 | 14696 | 0.010 |
Why?
|
|
Yang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|